BackgroundCheck.run
Search For

Allan J Darling, 64Mountain Lake Park, MD

Known as:
Allan James Darling Allen J Darling
Related to:
Elisabeth Posner Schouten 85 Elyssa A Darling 42 Robert A Darling 42 Andrew J Darling 40 Kathryn J Darling 64 Gloria G Cohen 74 Elizabeth I Darling 41

Allan Darling Phones & Addresses

Oakland, MD   

North Potomac, MD   

Rockville, MD   

Get Report
Control this profile

Mentions for Allan J Darling

Allan Darling resumes & CV records

Resumes

Allan Darling Photo 15

Allan Darling

Location:
1218 3Rd St, Langdon, ND 58249
Industry:
Biotechnology
Work:
Vtesse, Inc. Jan 2015 - Jun 2017
Vice President Technical Operations Caledonian Consulting Apr 2012 - Dec 2014
Chief Executive Officer Medimmune Apr 2006 - Apr 2012
Vice President Technical Operations and Qc Bioreliance 1995 - 2005
Senior Vice President Operations
Education:
University of Dundee 1982 - 1985
Doctorates, Doctor of Philosophy University of Dundee Jan 1, 1977 - 1981
Doctorates, Doctor of Philosophy University of Edinburgh School of Philosophy, Psychology and Language Sciences Jan 1, 1977 - 1981
Bachelors, Bachelor of Science, Microbiology
Skills:
Technology Transfer, Biotechnology, Gmp, Validation, Fda, Lifesciences, Pharmaceutical Industry, Sop, V&V, Change Control, Capa, Contract Manufacturing, Regulatory Affairs, Quality Assurance, Biopharmaceuticals, Drug Development, Vaccines, Commercialization, Elisa, Glp, Life Sciences, Medical Devices
Languages:
English
Allan Darling Photo 16

Vp Technical Operations At Medimmune

Location:
Washington D.C. Metro Area
Industry:
Biotechnology

Publications & IP owners

Wikipedia

Allan Darling Photo 17

Allan Cuthberts

Born Allan Darling Cuthbertson in Perth, Western Australia, he performed on stage and radio ... http://www.filmreference.com/film/35/Allan-Cuthbertson.html ...

Us Patents

Hydroxypropyl Beta-Cyclodextrin Compositions And Methods

US Patent:
2022028, Sep 8, 2022
Filed:
May 16, 2022
Appl. No.:
17/745464
Inventors:
- West Hollywood CA, US
Allan Darling - North Potomac MD, US
International Classification:
A61K 31/724
A61K 9/00
A61K 9/08
Abstract:
This disclosure provides mixtures of beta-cyclodextrin molecules substituted at one or more hydroxyl positions by hydroxypropyl groups, the mixture optionally including unsubstituted beta-cyclodextrin molecules, for use as a pharmaceutically active ingredient; methods of making such mixtures; methods of qualifying such mixtures for use in a pharmaceutical composition suitable for intrathecal or intracerebroventricular administration; pharmaceutical compositions suitable for intrathecal or intracerebroventricular administration comprising such mixtures; and methods of using the pharmaceutical compositions for treatment of Niemann-Pick disease Type C.

Hydroxypropyl Beta-Cyclodextrin Compositions And Methods

US Patent:
2022028, Sep 8, 2022
Filed:
May 16, 2022
Appl. No.:
17/745487
Inventors:
- West Hollywood CA, US
Allan Darling - North Potomac MD, US
International Classification:
A61K 31/724
A61K 9/00
A61K 9/08
Abstract:
This disclosure provides mixtures of beta-cyclodextrin molecules substituted at one or more hydroxyl positions by hydroxypropyl groups, the mixture optionally including unsubstituted beta-cyclodextrin molecules, for use as a pharmaceutically active ingredient; methods of making such mixtures; methods of qualifying such mixtures for use in a pharmaceutical composition suitable for intrathecal or intracerebroventricular administration; pharmaceutical compositions suitable for intrathecal or intracerebroventricular administration comprising such mixtures; and methods of using the pharmaceutical compositions for treatment of Niemann-Pick disease Type C.

Hydroxypropyl Beta-Cyclodextrin Compositions And Methods

US Patent:
2022028, Sep 8, 2022
Filed:
May 16, 2022
Appl. No.:
17/745491
Inventors:
- West Hollywood CA, US
Allan Darling - North Potomac MD, US
International Classification:
A61K 31/724
A61K 9/00
A61K 9/08
Abstract:
This disclosure provides mixtures of beta-cyclodextrin molecules substituted at one or more hydroxyl positions by hydroxypropyl groups, the mixture optionally including unsubstituted beta-cyclodextrin molecules, for use as a pharmaceutically active ingredient; methods of making such mixtures; methods of qualifying such mixtures for use in a pharmaceutical composition suitable for intrathecal or intracerebroventricular administration; pharmaceutical compositions suitable for intrathecal or intracerebroventricular administration comprising such mixtures; and methods of using the pharmaceutical compositions for treatment of Niemann-Pick disease Type C.

Hydroxypropyl Beta-Cyclodextrin Compositions And Methods

US Patent:
2022028, Sep 8, 2022
Filed:
May 16, 2022
Appl. No.:
17/745497
Inventors:
- West Hollywood CA, US
Allan Darling - North Potomac MD, US
International Classification:
A61K 31/724
A61K 9/00
A61K 9/08
Abstract:
This disclosure provides mixtures of beta-cyclodextrin molecules substituted at one or more hydroxyl positions by hydroxypropyl groups, the mixture optionally including unsubstituted beta-cyclodextrin molecules, for use as a pharmaceutically active ingredient; methods of making such mixtures; methods of qualifying such mixtures for use in a pharmaceutical composition suitable for intrathecal or intracerebroventricular administration; pharmaceutical compositions suitable for intrathecal or intracerebroventricular administration comprising such mixtures; and methods of using the pharmaceutical compositions for treatment of Niemann-Pick disease Type C.

Hydroxypropyl Beta-Cyclodextrin Compositions And Methods

US Patent:
2022028, Sep 8, 2022
Filed:
May 16, 2022
Appl. No.:
17/745505
Inventors:
- West Hollywood CA, US
Allan Darling - North Potomac MD, US
International Classification:
A61K 31/724
A61K 9/00
A61K 9/08
Abstract:
This disclosure provides mixtures of beta-cyclodextrin molecules substituted at one or more hydroxyl positions by hydroxypropyl groups, the mixture optionally including unsubstituted beta-cyclodextrin molecules, for use as a pharmaceutically active ingredient; methods of making such mixtures; methods of qualifying such mixtures for use in a pharmaceutical composition suitable for intrathecal or intracerebroventricular administration; pharmaceutical compositions suitable for intrathecal or intracerebroventricular administration comprising such mixtures; and methods of using the pharmaceutical compositions for treatment of Niemann-Pick disease Type C.

Hydroxypropyl Beta-Cyclodextrin Compositions And Methods

US Patent:
2022027, Sep 1, 2022
Filed:
May 16, 2022
Appl. No.:
17/745470
Inventors:
- West Hollywood CA, US
Allan Darling - North Potomac MD, US
International Classification:
A61K 31/724
A61K 9/00
A61K 9/08
Abstract:
This disclosure provides mixtures of beta-cyclodextrin molecules substituted at one or more hydroxyl positions by hydroxypropyl groups, the mixture optionally including unsubstituted beta-cyclodextrin molecules, for use as a pharmaceutically active ingredient; methods of making such mixtures; methods of qualifying such mixtures for use in a pharmaceutical composition suitable for intrathecal or intracerebroventricular administration; pharmaceutical compositions suitable for intrathecal or intracerebroventricular administration comprising such mixtures; and methods of using the pharmaceutical compositions for treatment of Niemann-Pick disease Type C.

Hydroxypropyl Beta-Cyclodextrin Compositions And Methods

US Patent:
2023009, Mar 30, 2023
Filed:
Nov 30, 2022
Appl. No.:
18/072260
Inventors:
- West Hollywood CA, US
Allan Darling - North Potomac MD, US
International Classification:
A61K 31/724
A61K 9/00
A61K 9/08
Abstract:
This disclosure provides mixtures of beta-cyclodextrin molecules substituted at one or more hydroxyl positions by hydroxypropyl groups, the mixture optionally including unsubstituted beta-cyclodextrin molecules, for use as a pharmaceutically active ingredient; methods of making such mixtures; methods of qualifying such mixtures for use in a pharmaceutical composition suitable for intrathecal or intracerebroventricular administration; pharmaceutical compositions suitable for intrathecal or intracerebroventricular administration comprising such mixtures; and methods of using the pharmaceutical compositions for treatment of Niemann-Pick disease Type C.

Hydroxypropyl Beta-Cyclodextrin Compositions And Methods

US Patent:
2023006, Mar 2, 2023
Filed:
Oct 20, 2022
Appl. No.:
17/970080
Inventors:
- West Hollywood CA, US
Allan Darling - North Potomac MD, US
International Classification:
A61K 31/724
A61K 9/00
A61K 9/08
Abstract:
This disclosure provides mixtures of beta-cyclodextrin molecules substituted at one or more hydroxyl positions by hydroxypropyl groups, the mixture optionally including unsubstituted beta-cyclodextrin molecules, for use as a pharmaceutically active ingredient; methods of making such mixtures; methods of qualifying such mixtures for use in a pharmaceutical composition suitable for intrathecal or intracerebroventricular administration; pharmaceutical compositions suitable for intrathecal or intracerebroventricular administration comprising such mixtures; and methods of using the pharmaceutical compositions for treatment of Niemann-Pick disease Type C.

Public records

Vehicle Records

Allan Darling

Address:
14031 Welland Ter, North Potomac, MD 20878
VIN:
WVWRU73C88E141276
Make:
VOLKSWAGEN
Model:
PASSAT
Year:
2008

Possible Relatives

Cynthia J Darling  David M Darling  Dawn M Darling  Dean C Darling  Deanna R Darling  Dale A Darling  Debora L Darling  Allan J Johnson  Allan F White  Allan Jones 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.